- Home
- PFBC vs ELVN Comparison
PFBC vs ELVN Comparison
Compare PFBC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFBC | ELVN |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1998 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PFBC | ELVN |
|---|---|---|
| Price | $87.34 | $27.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $102.67 | $41.00 |
| AVG Volume (30 Days) | 106.8K | ★ 1.6M |
| Earning Date | 01-22-2026 | 03-12-2026 |
| Dividend Yield | ★ 3.73% | N/A |
| EPS Growth | ★ 7.99 | N/A |
| EPS | ★ 10.41 | N/A |
| Revenue | ★ $281,236,000.00 | N/A |
| Revenue This Year | $5.05 | N/A |
| Revenue Next Year | $9.42 | N/A |
| P/E Ratio | $8.24 | ★ N/A |
| Revenue Growth | ★ 5.27 | N/A |
| 52 Week Low | $71.90 | $13.30 |
| 52 Week High | $103.05 | $29.98 |
Technical Indicators
Market Signals| Indicator | PFBC | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 69.11 |
| Support Level | $82.64 | $24.90 |
| Resistance Level | $85.35 | $28.69 |
| Average True Range (ATR) | 3.60 | 1.58 |
| MACD | -0.89 | 0.04 |
| Stochastic Oscillator | 32.19 | 80.11 |
Price Performance
Historical ComparisonAbout PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.